News Update on merger EC offered remedy proposal Staff November 20, 2023 Read the full announcement in PDF Attachment Update on merger EC offered remedy proposal Iframe sync Post navigation Previous: Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNext: Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission. More Stories Healthcare News Pharmaceutical President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way Staff December 13, 2025 Clinical Trial EHR Healthcare News Pharmaceutical Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT) Staff December 13, 2025 Clinical Trial News Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025 Staff December 13, 2025
